CRISIL reaffirms rating on commercial paper of Cadila Healthcare Ltd

CRISIL has, after due deliberations, reaffirmed its "CRISIL A1+" (pronounced as CRISIL A one plus rating) on the Rs. 1,300 crore Commercial Paper (enhanced from Rs. 250 crore) of Cadila Healthcare Ltd.

Shares of CADILA HEALTHCARE LTD. was last trading in BSE at Rs.426.15 as compared to the previous close of Rs. 426.05. The total number of shares traded during the day was 146056 in over 2440 trades.

The stock hit an intraday high of Rs. 426.95 and intraday low of 415.6. The net turnover during the day was Rs. 61704598.

Source : Equity Bulls

Keywords